Amy E Mc Kee Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

BCRX Quotes by TradingView

Amy E Mc Kee is Director of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 27,831 shares of BCRX, which is worth approximately $211,515. The most recent transaction as insider was on Jun 24, 2024, when has been sold 8,600 shares (Common Stock) at a price of $6.32 per share, resulting in proceeds of $54,352. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.8K
0% 3M change
6.01% 12M change
Total Value Held $211,515

Amy E McKee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2024
SELL
Open market or private sale
$54,352 $6.32 p/Share
8,600 Reduced 23.61%
27,831 Common Stock
Jun 12 2024
BUY
Grant, award, or other acquisition
-
6,820 Added 15.77%
36,431 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
16,745 Added 36.12%
29,611 Common Stock
Jun 07 2022
BUY
Grant, award, or other acquisition
-
12,866 Added 50.0%
12,866 Common Stock
AEM

Amy E Mc Kee

Director
Durham, NC

Track Institutional and Insider Activities on BCRX

Follow BIOCRYST PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCRX